9 Elderly - HH Flashcards

1
Q

Why is prescribing in older people difficult (4)

A

Multiple pathology
Polypharmacy
Difficulties with adherence
Altered drug handling (physically and PK/PD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Problem with multiple pathology (2)

A

interaction between disease states and medicines

lack of appropriate trial data

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Unintentional non-adherance issues (5)

A
Physical difficulty with pack/device
poor swallow
confusion/memory problems
lack of info/poor communication
complicated regieme
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

intentional adherence issues 5

A
deliberate adjustments
lack of confidence in med/Rxer
S/e (and concerns about these)
lack of info/poor communication
complicated regieme
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Improving adherance ideas 4

A

assess use of meds - poping out/inhalers/eye drops
large print labels
plain top bottles
med reminder card

dosset box!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the issues with MCA (multicomparment compliance aids)

(4)

A

need to understand how to use it
take away independence/understanding
many filled to allow carer to prompt

Off label
Stability issues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What to assess before offering compliance aid

A
knowledge
visual
manual dexterity
cognition
supply
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Where can you look up if a drug is stable in a compliance aid

A

medicines compliance aid database

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Where can you look up if a drug is stable in a compliance aid

A

medicines compliance aid database

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Changes in absorption:

2 exceptions

A

reduced by all routes but extent unchanged

Reduced absorption of vit
increased absorption of levodopa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Changes in distribution

A

Slower distribution.

Reduced water so increased conc of water soluble drugs (dig/gent/theophylline/Li)

Increased fat - prolonged effects of fat soluble (diazepam/phenytoin)

Reduced albumin - increase protein bound drug conc (NSAIDs/furosemide)

Reduced muscle (increased digoxin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Changes in metabolism

A

largely there is reserve so ? significance

reduced hepatic perfusion
reduced 1st pass
reduced hepatic enzymes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Changes in elimination

A

predictable agerelated decrease in renal func

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Renal func problems in eledery worsened by

A

diabetes
infection
cardiac failure
dehydration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Pharmacodynamic changes

A
"What the drug does to the body"
changes in target organ responsiveness
loss of homeostatic mechanism
changes in target receptor sensitivity
(increased effect of CNS acting drugs, decreased efficacy of beta blockers)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Principles of safe prescribing 4

A

start low/go slow
simple regiemes
watch for s/e and interactions and efficacy
set clear theraputic goals

17
Q

7 examples from the STOPP /START tools of inappriopraite prescribing with comorbidities

  1. Dig in …
  2. Neuroleptics…
  3. Metoclopramide….
  4. NSAIDs….
  5. Warfarin….
  6. ACEi …..
  7. Bisphophinates…
A
  1. Long term digoxin > 125mcg with impaired renal function
  2. Neuroleptics as long term hypnotics
  3. Metoclopramide in Parkinson’s disease
  4. NSAID in heart failure
  5. Warfarin in chronic AF
  6. ACE-I in chronic heart failure
  7. Bisphosphonates in patients on maintenance corticosteroids